sábado, 11 de junio de 2016

FDA finalizes interim policy on compounding using bulk drug substances- Drug Information Update

FDA logo, hand holding tablets, Division of Drug Information, Know the moment it happens
The Division of Drug Information (DDI)- serving the public by providing information on human drug products and drug product regulation by FDA.

Today the FDA issued two final guidances on compounding using bulk substances:
The agency also posted a statement and a webpage related to these two guidances: 
For more information on pharmacy compounding, go to FDA’s Information on Compounding

No hay comentarios: